Clinical Trials Directory

Trials / Conditions / Chemotherapeutic Agent Toxicity

Chemotherapeutic Agent Toxicity

34 registered clinical trials studyying Chemotherapeutic Agent Toxicity2 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingMalnutrition and Sarcopenia Screening in Chemotherapy Patients
NCT07163286
Çanakkale Onsekiz Mart University
RecruitingInvestigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.
NCT06387901
Universitair Ziekenhuis Brussel
RecruitingTelemonitoring Platforms and Chemotherapy-Associated Toxicity
NCT06077123
Universidad Nacional Andres BelloN/A
CompletedDiminish Chemotherapy Related Side Effects Through Patient Education
NCT04694794
Milton S. Hershey Medical CenterN/A
UnknownMobile App for Symptoms Monitoring in Cancer Patients: a Pilot Study
NCT04572282
Associacao de Investigacao de Cuidados de Suporte em OncologiaN/A
UnknownCryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing
NCT04632797
Medical University InnsbruckN/A
WithdrawnSublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)
NCT01562301
M.D. Anderson Cancer CenterPhase 1
TerminatedGlutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib
NCT01783522
Beth FaimanPhase 2
CompletedRituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radia
NCT01399372
Radiation Therapy Oncology GroupPhase 2
TerminatedCryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Recei
NCT01243541
Northwestern UniversityN/A
CompletedCalcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Ca
NCT01099449
Alliance for Clinical Trials in OncologyPhase 3
CompletedGlutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian
NCT02311907
Alliance for Clinical Trials in OncologyPhase 3
CompletedS0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing
NCT00775645
SWOG Cancer Research NetworkPhase 3
UnknownFirst-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Sma
NCT01097317
Wales Cancer Trials UnitPhase 2
CompletedElectrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemother
NCT00952848
Virginia Commonwealth UniversityPhase 2
TerminatedSelenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receivin
NCT01682031
Roswell Park Cancer InstitutePhase 2
CompletedCalcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorec
NCT00748215
M.D. Anderson Cancer CenterPhase 2
CompletedAcute Pain Caused by Paclitaxel in Patients With Cancer
NCT00860041
Alliance for Clinical Trials in Oncology
CompletedCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithe
NCT00814086
Gynecologic Oncology GroupPhase 1
CompletedMethotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous S
NCT00727831
University College, LondonPhase 1 / Phase 2
TerminatedAerobic Exercise in Patients Receiving Chemotherapy for Cancer
NCT00728429
Wake Forest University Health SciencesN/A
CompletedCardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorub
NCT00577798
University of Nebraska
CompletedG-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy
NCT00770172
Centre Francois BaclessePhase 3
SuspendedKidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors
NCT00695032
Institut Claudius RegaudN/A
CompletedG-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer
NCT00771433
Centre Francois BaclessePhase 2
TerminatedChemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer
NCT00662688
GERCOR - Multidisciplinary Oncology Cooperative GroupPhase 3
UnknownBiomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
NCT00884767
Institut Cancerologie de l'OuestPhase 2
TerminatedNicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Brea
NCT00751101
University of California, San FranciscoPhase 2
UnknownCYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide
NCT00514345
Children's Cancer and Leukaemia Group
CompletedEffects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
NCT00755313
University of California, San Francisco
TerminatedL-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Bre
NCT00754767
HealthPartners InstitutePhase 4
CompletedChanges in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent P
NCT00499798
Wake Forest University Health Sciences
CompletedRandomized Amifostine For SCCHN
NCT00095927
Dana-Farber Cancer InstitutePhase 2
CompletedUsing Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment
NCT00608738
Northwestern UniversityN/A